Company Overview
Snapshot
Founded in June 2020 by Orr Inbar and Arnon Horev, QuantHealth is a Health Tech & Life Sciences company with 51–200 employees. The company has raised $66.01M across 6 disclosed funding rounds from 13 investors. In August 2026, QuantHealth secured $45M in its latest funding round, led by Qumra Capital.
Business overview
QuantHealth is an AI company focused on accelerating and de-risking drug development through patient-centric drug simulations. Its AI solution enables Clinical Development and Clinical Operations teams to holistically simulate clinical trials in thousands of variations within minutes, evaluating parameters for endpoint success, commercial viability, and protocol feasibility. The in-silico platform generates synthetic evidence on therapy performance across all clinical phases, supporting trial planning, indication selection, drug repurposing, and in-licensing asset evaluation. The company's Large Healthcare Model learns deep patient-drug interactions to drive high-resolution outcome models with 86% endpoint accuracy, continually adapting to new research and internal trial data.
Strategic signal
In April 2024, QuantHealth appointed esteemed pharmaceutical executives to its inaugural Advisory Board. This strategic move signals the company's intent to deepen its industry expertise and expand its network within the pharmaceutical sector, which is crucial for validating its AI-driven clinical trial simulation technology and accelerating market adoption among major drug developers.
Log in to access full profile ›Company Intelligence Q&A
- What was QuantHealth's most recent funding round?
- In August 2026, QuantHealth raised $45M in a B Round, with Qumra Capital as a lead investor.
- Which investors participated in QuantHealth's August 2023 funding round?
- In August 2023, QuantHealth received funding in an A Round led by Pitango HealthTech.
- When did Accenture Ventures invest in QuantHealth?
- In January 2024, Accenture Ventures led an A Round investment in QuantHealth to accelerate the use of AI-powered clinical trial simulations.
- What strategic partnership did QuantHealth announce in March 2022?
- In March 2022, QuantHealth partnered with 4P-Pharma to conduct AI-based in-silico clinical trial simulations, aiming to enhance drug development processes.
- When did QuantHealth establish its Advisory Board?
- In April 2024, QuantHealth appointed several esteemed pharmaceutical executives to its inaugural Advisory Board.